Publication | Open Access
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
38
Citations
27
References
2022
Year
These are the first large-scale studies to demonstrate the efficacy and safety profiles of 200 mg/d and 400 mg/d centanafadine in adults with ADHD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1